The opioid epidemic remains one of the most pressing public health challenges in the United States. Prescription opioid misuse affects millions of Americans each year, and pharmacists are uniquely positioned to make a real difference. As the last line of defense before a medication reaches a patient, you have the knowledge, access, and opportunity to support safer opioid use every single day.
Opioid stewardship is about more than just dispensing medications correctly. It’s a proactive, collaborative approach to ensuring opioids are prescribed and used appropriately, safely, and only when necessary. This post covers the key principles every pharmacist should know to practice effective opioid stewardship, from patient assessment to monitoring and education.
What is opioid stewardship?
Opioid stewardship refers to the coordinated efforts of healthcare professionals to improve how opioids are prescribed, dispensed, and monitored. The goal is to reduce misuse, dependence, and overdose while still ensuring patients with legitimate pain needs receive effective treatment.
Pharmacists play a central role in this effort. You’re not just filling prescriptions; you’re validating clinical decisions, catching red flags, counseling patients, and connecting people to the right resources.
Related CE course for pharmacists: Chronic Pain Management: Non-Opioid Therapies
Recognizing appropriate vs. inappropriate opioid prescribing
Understanding what good opioid prescribing looks like helps you identify when something isn’t right. According to best practices, appropriate opioid therapy should:
- Start at the lowest effective dose
- Use short-acting formulations before long-acting options
- Be combined with non-opioid and non-pharmacological therapies
- Include a defined treatment trial period (typically no more than 30 days)
- Be supported by documented informed consent and a treatment agreement
Prescribers should avoid combining opioids with benzodiazepines whenever possible. This combination significantly increases the risk of respiratory depression and overdose. The FDA has issued black box warnings about this, and it’s something you can flag during prescription review.
Red flags that may indicate inappropriate use or diversion include:
- Multiple prescribers or multiple pharmacies
- Requests for early refills
- Cash payments when insurance is available
- Geographic inconsistencies (filling prescriptions far from home)
- Prescriptions from emergency departments for chronic conditions
When you spot these patterns, you have an important role to play, both in patient safety and in supporting prescribers with the information they need.
Related CE course for pharmacists: Opioid Safety: Balancing Benefits and Risks
The pharmacist’s role in risk assessment
Risk stratification is a key part of opioid stewardship. Not every patient carries the same risk of misuse or dependence, and care plans should reflect that.
Several validated tools exist to help assess patient risk, including:
- Opioid Risk Tool (ORT): A 5-item patient-administered questionnaire
- SOAPP-R: A 24-item screener for patients with pain
- Current Opioid Misuse Measure (COMM): A 17-item tool that identifies aberrant behaviors in patients already on long-term opioid therapy
While pharmacists may not administer these tools directly, understanding them helps you interpret clinical notes, identify inconsistencies, and have more informed conversations with prescribers and patients.
Risk factors associated with opioid misuse include a personal or family history of substance use disorder, mental health conditions, young age, and a history of trauma or legal issues. When these factors are present, enhanced monitoring becomes especially important.
Monitoring patients on long-term opioid therapy
Effective opioid stewardship doesn’t stop at dispensing. Ongoing monitoring is critical to catching problems early. A widely used framework for this is the 5 A’s:
- Analgesia: Is the patient’s pain adequately controlled?
- Activity: Has their daily functioning improved?
- Adverse effects: Are side effects being managed?
- Aberrant drug-related behaviors: Are there signs of misuse?
- Affect: How is the patient’s mood?
Reviewing these areas at each patient interaction, even briefly, can help identify when a treatment plan needs to change.
Testing and monitoring plans
Urine drug testing (UDT) is another key monitoring tool. Recommended testing frequency varies based on risk level:
- Low risk: Every 1–2 years
- Medium risk: Every 6–12 months
- High risk: Every 3–6 months
It’s important to understand UDT’s limitations, though. Immunoassay screens have relatively high false-positive and false-negative rates and shouldn’t be used as the sole basis for major clinical decisions. A positive or negative result should prompt a supportive conversation with the patient, not an automatic punitive response.
Prescription Drug Monitoring Programs (PDMPs) are another powerful tool. Checking a patient’s controlled substance history before dispensing can reveal patterns that aren’t visible in any single prescription. Many states require PDMP checks for certain medications but making it a routine practice for all opioid prescriptions is a strong stewardship habit.
The VIGIL framework for pharmacists
The VIGIL framework was specifically designed to help pharmacists resolve ambiguous opioid prescriptions while preserving legitimate patient need. Each component guides your decision-making:
- Verification: Is this a responsible opioid user?
- Identification: Can you verify the patient’s identity?
- Generalization: Do you and the patient share mutual expectations?
- Interpretation: Do you feel comfortable dispensing to this person?
- Legalization: Are you acting legally and responsibly?
VIGIL works best when built on a collaborative relationship between pharmacists and prescribers. When you have concerns, reaching out to the prescriber isn’t overstepping; it’s good clinical practice.
Patient counseling: A key stewardship opportunity
Every time you dispense an opioid, you have a counseling opportunity that can meaningfully improve patient safety. Key topics to cover include:
- Safe use: Take only as prescribed; never crush, chew, or break extended-release formulations
- Drug interactions: Avoid alcohol, benzodiazepines, and other CNS depressants
- Storage: Keep medications locked and out of reach of children and others in the household
- Disposal: Use local take-back programs or authorized collection sites whenever possible. For specific products like OxyContin and transdermal fentanyl, the FDA recommends flushing when a take-back option isn’t available
- Overdose recognition: Counsel patients and caregivers on the signs of opioid overdose and the appropriate use of naloxone
Naloxone access is a critical part of opioid stewardship. High-risk patients—those on doses above 50 morphine milligram equivalents (MME) per day, those with a history of substance use disorder, or those co-prescribed benzodiazepines—should be offered naloxone. Many states now allow pharmacists to dispense naloxone without a prescription. Knowing your state’s laws and actively offering it to at-risk patients is one of the most direct ways you can save lives.
Supporting safe discontinuation
When opioid therapy needs to end, how it ends matters. Abrupt discontinuation can cause severe withdrawal and put patients at risk. A gradual tapering protocol—typically a 10% dose reduction per week, though the rate should be individualized—is the standard approach.
Patients should be reassured that stopping opioids isn’t the end of their pain management. Other modalities, including non-opioid medications and non-pharmacological therapies, can continue to provide relief. Your role here is to support the transition, answer questions about withdrawal symptoms, and encourage follow-through with the prescriber’s plan.
Keep growing your opioid stewardship knowledge
Opioid prescribing guidelines continue to evolve. The 2024 Federation of State Medical Boards (FSMB) guideline, CDC recommendations, and state-specific regulations all inform current best practices—and staying current is part of practicing responsibly.
Continuing education is one of the most effective ways to deepen your expertise and strengthen your stewardship practice. Courses focused on opioid risk assessment, patient counseling, monitoring tools, and treatment planning equip you to handle complex cases with confidence.
You’re at the center of opioid stewardship
Pharmacists have more influence over opioid safety than many people realize. Every interaction—whether it’s a prescription review, a counseling session, or a conversation with a prescriber—is a chance to protect a patient.
Effective opioid stewardship isn’t just about preventing harm. It’s about ensuring that patients who need pain relief get it safely, that those at risk are identified early, and that the entire healthcare team works together toward better outcomes.
